XML 10 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating activities    
Net loss $ (4,637,066) $ (1,352,824)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 9,898 5,311
Stock-based compensation 587,677 118,980
Non-cash interest on convertible notes 1,831,940 30,800
Non-cash discount amortization on convertible notes 233,223
Revaluation of convertible notes 125,574
Revaluation of premium conversion derivatives and warrant liability 12,954
Issuance costs attributed to financing activities 865,567
Change in assets and liabilities:    
Prepaid and other assets (332,075) (26,814)
Accounts payable and other accrued liabilities 323,639 278,686
Net cash used in operating activities (1,224,846) (699,684)
Investing activities    
Purchase of fixed assets (10,271)
Net cash used in investing activities (10,271)
Financing activities    
Proceeds from issuance of convertible promissory notes 3,234,800
Issuance costs related to convertible notes (417,176)
Proceeds from unsecured loans 245,000
Proceeds from issuance of common stock in connection with private placements 255,000 601,649
Proceeds from issuance of warrants in connection with private placements 223,351
Proceeds from advances related to private placement 40,000
Issuance costs related to private placements (53,954) (73,000)
Net cash provided by financing activities 3,018,670 1,037,000
Net increase in cash 1,783,553 337,316
Cash at beginning of period 260,749 13,260
Cash at end of period 2,044,302 350,576
Supplemental non-cash financing and investing transactions:    
Unpaid issuance costs attributed to convertible notes and private placement 28,756 76,316
Broker warrants issued in connection with convertible notes 419,635 76,316
Purchased fixed assets in accounts payable and accrued expenses $ 10,271